Defeng Y. Qi
Guangdong Key Laboratory Of Urology
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Portrayed the development of activated T cell to exhausted T cell based on the ratio of CD28 to CTLA4.
Journal: Cancer immunology, immunotherapy : CII
Published: July 22, 2025
Application and evaluation of HB&L system in the rapid diagnosis of urinary tract infection.
Journal: Translational andrology and urology
Published: February 12, 2025
Correlation between benign prostatic hyperplasia and comorbidities: a systematic analysis integrating global burden of disease and mendelian randomization study.
Journal: Journal of translational medicine
Published: February 23, 2024
Circular RNA LMBR1 inhibits bladder cancer progression by enhancing expression of the protein ALDH1A3.
Journal: Non-coding RNA research
Published: October 19, 2023
Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients.
Journal: Frontiers in immunology
Published: August 01, 2022
METTL1-m7 G-EGFR/EFEMP1 axis promotes the bladder cancer development.
Journal: Clinical and translational medicine
Published: August 31, 2021
Programmable N6-methyladenosine modification of CDCP1 mRNA by RCas9-methyltransferase like 3 conjugates promotes bladder cancer development.
Journal: Molecular cancer
Published: October 05, 2020
The application of indocyanine green in guiding prostate cancer treatment.
Journal: Asian journal of urology
Published: August 10, 2020
A novel regulatory circuit of miR‑152 and DNMT1 in human bladder cancer.
Journal: Oncology reports
Published: February 14, 2018
Last Updated: 09/26/2026